![DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012 DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012](https://journals.sagepub.com/cms/10.1177/1759720X12444710/asset/images/large/10.1177_1759720x12444710-fig1.jpeg)
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012
![A Randomized Control Trial Comparing Oral Ibuprofen at Three Single-Dose Regimens for Treating Acute Pain in the ED - REBEL EM - Emergency Medicine Blog A Randomized Control Trial Comparing Oral Ibuprofen at Three Single-Dose Regimens for Treating Acute Pain in the ED - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2019/07/Ibuprofen-Critical-Results.jpg)
A Randomized Control Trial Comparing Oral Ibuprofen at Three Single-Dose Regimens for Treating Acute Pain in the ED - REBEL EM - Emergency Medicine Blog
![Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027](http://www.researchandmarkets.com/product_images/12380/12380637_500px_jpg/intravenous_iv_ibuprofen_market.jpg)
Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
![DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012 DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012](https://journals.sagepub.com/cms/10.1177/1759720X12444710/asset/images/large/10.1177_1759720x12444710-fig2.jpeg)
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug - Alfonso E. Bello, 2012
![Clinical Conundrum: Does IM Ketorolac Provide Superior Pain Relief to PO Ibuprofen? - REBEL EM - Emergency Medicine Blog Clinical Conundrum: Does IM Ketorolac Provide Superior Pain Relief to PO Ibuprofen? - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2023/08/Screenshot-2023-08-16-at-4.35.12-PM.jpg)
Clinical Conundrum: Does IM Ketorolac Provide Superior Pain Relief to PO Ibuprofen? - REBEL EM - Emergency Medicine Blog
![CVS Health Ibuprofen Pain Reliever & Fever Reducer (NSAID) 200 MG Coated Tablets | Pick Up In Store TODAY at CVS CVS Health Ibuprofen Pain Reliever & Fever Reducer (NSAID) 200 MG Coated Tablets | Pick Up In Store TODAY at CVS](https://www.cvs.com/bizcontent/merchandising/productimages/large/50428326022.jpg)